Q/C Technologies, Inc.
QCLS- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001321834
No open-market purchases or sales by Q/C Technologies, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.87M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Q/C Technologies, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 20 | 25 | +5 |
| Shares | 37.2K | 126.9K | +89.6K (+240.6%) |
| Value | $60.3K | $145.8K | +$85.6K (+141.9%) |
New holders (6)
Institutions that held Q/C Technologies, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 22,874 | $26.3K | 0.00% |
| Legacy Investment Solutions, LLC | 60 | $35 | 0.00% |
| Legacy Wealth Managment, LLC | 60 | $35 | 0.00% |
| MAI Capital Management | 5 | $6 | 0.00% |
| Dogwood Wealth Management LLC | 3 | $3 | 0.00% |
| SBI Securities Co., Ltd. | 1 | $1 | 0.00% |
Sold out (1)
Institutions that held Q/C Technologies, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Newbridge Financial Services Group, Inc. | 34 | $55 |